198 related articles for article (PubMed ID: 33567036)
21. High intensity 125-iodine (125I) plaque treatment of uveal melanoma.
Quivey JM; Char DH; Phillips TL; Weaver KA; Castro JR; Kroll SM
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):613-8. PubMed ID: 8330990
[TBL] [Abstract][Full Text] [Related]
22. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
23. Transscleral local resection versus iodine brachytherapy for uveal melanomas that are large because of tumour height.
Puusaari I; Damato B; Kivelä T
Graefes Arch Clin Exp Ophthalmol; 2007 Apr; 245(4):522-33. PubMed ID: 17111148
[TBL] [Abstract][Full Text] [Related]
24. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
25. Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management.
Bellerive C; Aziz HA; Bena J; Wilkinson A; Suh JH; Plesec T; Singh AD
Am J Ophthalmol; 2017 May; 177():9-16. PubMed ID: 28163118
[TBL] [Abstract][Full Text] [Related]
26. Postoperative Echography for Optimization of Radiation Dosimetry in Patients with Uveal Melanoma Treated with Plaque Brachytherapy.
Binkley EM; King BA; Hyer DE; Javed A; Milhem MM; Hinz CJ; Mott SL; Boldt HC
Ophthalmol Retina; 2023 Jul; 7(7):620-627. PubMed ID: 36822323
[TBL] [Abstract][Full Text] [Related]
27. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
28. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
[TBL] [Abstract][Full Text] [Related]
29. Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy.
Char DH; Kroll S; Quivey JM; Castro J
Br J Ophthalmol; 1996 Feb; 80(2):117-24. PubMed ID: 8814740
[TBL] [Abstract][Full Text] [Related]
30. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
[TBL] [Abstract][Full Text] [Related]
31. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
McCannel TA; McCannel CA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
[TBL] [Abstract][Full Text] [Related]
32. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
33. [The clinical observation of external scleral plaque radiotherapy in patients with uveal melanoma].
Liu YM; Zhou N; Wei WB; Wang P
Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):670-675. PubMed ID: 32907299
[No Abstract] [Full Text] [Related]
34. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
[TBL] [Abstract][Full Text] [Related]
35. Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma.
Sener EC; Kiratli H; Gedik S; Sanac AS
J AAPOS; 2004 Feb; 8(1):38-45. PubMed ID: 14970798
[TBL] [Abstract][Full Text] [Related]
36. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
[TBL] [Abstract][Full Text] [Related]
37. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
38. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
39. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
40. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]